ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Merck pays $760M to buy into KalVista drug
biospectrumasia
October 12, 2017DME is an accumulation of fluid in the eye that can cause sight loss, and has also agreed to provide up to $715 million in milestones plus royalties if it leads to a commercial product
Pharma Sources Insight January 2025
